跳至主要内容
临床试验/ITMCTR2200006734
ITMCTR2200006734尚未招募1 期

The Efficacy of Xiaoyu Xiezhuo Decoction on Chronic Kidney Disease in Stage 3-4: a Multicenter Clinical Study

Zhejiang Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • (1) Patients who meet the diagnostic criteria of ckd3-4 of Western medicine;
  • (2) Meet the TCM standards for qi deficiency and stasis;
  • (3) Patients aged 18-75 years old, without gender limitation, and who have not received dialysis treatment;
  • (4) Blood pressure = 140 / 90mmHg after basic hypotension;
  • (5) The primary diseases are chronic glomerulonephritis, hypertension, diabetes, hepatitis B Related Nephritis and so on, and the disease is stable;
  • (6) The patient agreed to the treatment of the study, joined the chronic disease management, and signed the informed consent;
  • (7) No other drug tests have been conducted in the last 3 months or the effective drug elution period has passed

排除标准

  • (1) Patients with acute infectious diseases and surgical and traumatic stress;
  • (2) Patients with chronic infectious diseases, such as chronic hepatitis B in the active phase and delayed migration, cirrhosis in the decompensated phase or active tuberculosis;
  • (3) Diseases with severe organ function damage affecting the survival of patients, such as malignant tumors and HIV infection;
  • (4) Patients with serious primary diseases such as cardiovascular, blood system, digestive system and respiratory system;
  • (5) Those who have a history of major bleeding or blood transfusion in the past 3 months, have signs of serious clinical infection and acidosis, complicated with hyperkalemia, heart failure and other life-threatening patients;
  • (6) Severe allergic constitution, allergic or intolerable to certain drugs known in the study;
  • (7) Pregnant or lactating patients;
  • (8) Have a history of drug abuse;
  • (9) Patients with primary polycystic kidney disease;
  • (10) Patients who are participating in other clinical trials or who use other traditional Chinese medicine in the same period to affect the judgment of efficacy;
  • (11) The fluctuation range of eGFR within 3 months before enrollment was = 30%;
  • (12) Those who are ready for or have adopted renal transplantation, and those who have acute renal failure, chronic renal failure with acute exacerbation and need immediate replacement treatment;
  • (13) Acute renal injury caused by post renal factors, such as obstruction (including renal calculi, urate crystals, tumors, etc.);
  • (14) Patients with a history of psychosis or communication and cognitive impairment who have poor compliance and cannot cooperate.

研究者

发起方
Zhejiang Hospital of Traditional Chinese Medicine

相似试验

The Efficacy of Xiaoyu Xiezhuo Decoction on Chronic... | 临床试验